Clinical Trial Update: Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether early administration of tranexamic acid reduces blood loss and the need for perioperative transfusion in hip fracture surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture
• Intertrochanteric Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Mayo Clinic | Conditions: Hip Fractures, Intertrochanteric Fractures | Phase 2 | Status: COMPLETED | Results posted: 2023-03-30